Alpha Thalassemia Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Type (Silent Alpha Thalassemia Carrier, Alpha Thalassemia Minor, Alpha Thalassemia Trait, Hemoglobin H Disease, Alpha Thalassemia Major, Hydrops Fetalis); Diagnosis (Prenatal Testing, Perinatal Testing, Pre-Implantation); End User (Hospitals, Diagnostic Laboratories, Others)
Report Code: TIPRE00004472 No. of Pages: 150 Category: Biotechnology Status: Upcoming
MARKET INTRODUCTION
Thalassemia is a group of blood illnesses that distress the system the body makes hemoglobin. Hemoglobin is a protein found in red blood cells and it carries oxygen throughout the body. The main components that make hemoglobin are of alpha globin and beta globin. When one or more of the genes, controlling the formation of alpha globins is absent or defective it forms alpha thalassemia.
MARKET DYNAMICS
The alpha thalassemia market is expected to grow during forecast period owing to key factors such as rising awareness about the disease, rising incidences of congenital birth defects and increasing number of the genetic disorders. The rise in healthcare expenditures are likely to create growth opportunities in the market.
MARKET SCOPE
The "Global Alpha Thalassemia Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of alpha thalassemia market with detailed market segmentation by type, diagnosis, end user and geography. The global alpha thalassemia market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading alpha thalassemia market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global alpha thalassemia market is segmented on the basis of type, diagnosis and end user. Based on the type market is segmented as silent alpha thalassemia carrier, alpha thalassemia minor, alpha thalassemia trait, hemoglobin H disease, alpha thalassemia major and hydrops fetalis. On the basis of diagnosis the market is classified as prenatal testing, perinatal testing and pre-implantation. Based on the end user the market is divided into hospitals, diagnostic laboratories and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global alpha thalassemia market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The alpha thalassemia market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting alpha thalassemia market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the alpha thalassemia market in these regions.
MARKET PLAYERS
The reports cover key developments in the alpha thalassemia market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from alpha thalassemia market are anticipated to lucrative growth opportunities in the future with the rising demand for alpha thalassemia market in the global market. Below mentioned is the list of few companies engaged in the alpha thalassemia market.
The report also includes the profiles of key alpha thalassemia market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Thalassemia is a group of blood illnesses that distress the system the body makes hemoglobin. Hemoglobin is a protein found in red blood cells and it carries oxygen throughout the body. The main components that make hemoglobin are of alpha globin and beta globin. When one or more of the genes, controlling the formation of alpha globins is absent or defective it forms alpha thalassemia.
MARKET DYNAMICS
The alpha thalassemia market is expected to grow during forecast period owing to key factors such as rising awareness about the disease, rising incidences of congenital birth defects and increasing number of the genetic disorders. The rise in healthcare expenditures are likely to create growth opportunities in the market.
MARKET SCOPE
The "Global Alpha Thalassemia Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of alpha thalassemia market with detailed market segmentation by type, diagnosis, end user and geography. The global alpha thalassemia market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading alpha thalassemia market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global alpha thalassemia market is segmented on the basis of type, diagnosis and end user. Based on the type market is segmented as silent alpha thalassemia carrier, alpha thalassemia minor, alpha thalassemia trait, hemoglobin H disease, alpha thalassemia major and hydrops fetalis. On the basis of diagnosis the market is classified as prenatal testing, perinatal testing and pre-implantation. Based on the end user the market is divided into hospitals, diagnostic laboratories and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global alpha thalassemia market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The alpha thalassemia market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting alpha thalassemia market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the alpha thalassemia market in these regions.
MARKET PLAYERS
The reports cover key developments in the alpha thalassemia market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from alpha thalassemia market are anticipated to lucrative growth opportunities in the future with the rising demand for alpha thalassemia market in the global market. Below mentioned is the list of few companies engaged in the alpha thalassemia market.
The report also includes the profiles of key alpha thalassemia market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Trinity Biotech Plc
- Novus Biologicals
- Viennalab Diagnostics Gmbh
- Bio-Rad Laboratories, Inc
- Thermofisher Scienific Corporation Inc
- Sebia
- Bluebird Bio, Inc.
- Natera, Inc.
- EKF Diagnostics
- Sangamo Therapeutics
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Alpha Thalassemia Market - By Type
1.3.2 Alpha Thalassemia Market - By Diagnosis
1.3.3 Alpha Thalassemia Market - By End User
1.3.4 Alpha Thalassemia Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ALPHA THALASSEMIA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ALPHA THALASSEMIA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ALPHA THALASSEMIA MARKET - GLOBAL MARKET ANALYSIS
6.1. ALPHA THALASSEMIA - GLOBAL MARKET OVERVIEW
6.2. ALPHA THALASSEMIA - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ALPHA THALASSEMIA MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SILENT ALPHA THALASSEMIA CARRIER
7.3.1. Overview
7.3.2. Silent Alpha Thalassemia Carrier Market Forecast and Analysis
7.4. ALPHA THALASSEMIA MINOR
7.4.1. Overview
7.4.2. Alpha Thalassemia Minor Market Forecast and Analysis
7.5. ALPHA THALASSEMIA TRAIT
7.5.1. Overview
7.5.2. Alpha Thalassemia Trait Market Forecast and Analysis
7.6. HEMOGLOBIN H DISEASE
7.6.1. Overview
7.6.2. Hemoglobin H Disease Market Forecast and Analysis
7.7. ALPHA THALASSEMIA MAJOR
7.7.1. Overview
7.7.2. Alpha Thalassemia Major Market Forecast and Analysis
7.8. HYDROPS FETALIS
7.8.1. Overview
7.8.2. Hydrops Fetalis Market Forecast and Analysis
8. ALPHA THALASSEMIA MARKET - REVENUE AND FORECASTS TO 2027 - DIAGNOSIS
8.1. OVERVIEW
8.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
8.3. PRENATAL TESTING
8.3.1. Overview
8.3.2. Prenatal Testing Market Forecast and Analysis
8.4. PERINATAL TESTING
8.4.1. Overview
8.4.2. Perinatal Testing Market Forecast and Analysis
8.5. PRE-IMPLANTATION
8.5.1. Overview
8.5.2. Pre-Implantation Market Forecast and Analysis
9. ALPHA THALASSEMIA MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTIC LABORATORIES
9.4.1. Overview
9.4.2. Diagnostic Laboratories Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. ALPHA THALASSEMIA MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Alpha Thalassemia Market Overview
10.1.2 North America Alpha Thalassemia Market Forecasts and Analysis
10.1.3 North America Alpha Thalassemia Market Forecasts and Analysis - By Type
10.1.4 North America Alpha Thalassemia Market Forecasts and Analysis - By Diagnosis
10.1.5 North America Alpha Thalassemia Market Forecasts and Analysis - By End User
10.1.6 North America Alpha Thalassemia Market Forecasts and Analysis - By Countries
10.1.6.1 United States Alpha Thalassemia Market
10.1.6.1.1 United States Alpha Thalassemia Market by Type
10.1.6.1.2 United States Alpha Thalassemia Market by Diagnosis
10.1.6.1.3 United States Alpha Thalassemia Market by End User
10.1.6.2 Canada Alpha Thalassemia Market
10.1.6.2.1 Canada Alpha Thalassemia Market by Type
10.1.6.2.2 Canada Alpha Thalassemia Market by Diagnosis
10.1.6.2.3 Canada Alpha Thalassemia Market by End User
10.1.6.3 Mexico Alpha Thalassemia Market
10.1.6.3.1 Mexico Alpha Thalassemia Market by Type
10.1.6.3.2 Mexico Alpha Thalassemia Market by Diagnosis
10.1.6.3.3 Mexico Alpha Thalassemia Market by End User
10.2. EUROPE
10.2.1 Europe Alpha Thalassemia Market Overview
10.2.2 Europe Alpha Thalassemia Market Forecasts and Analysis
10.2.3 Europe Alpha Thalassemia Market Forecasts and Analysis - By Type
10.2.4 Europe Alpha Thalassemia Market Forecasts and Analysis - By Diagnosis
10.2.5 Europe Alpha Thalassemia Market Forecasts and Analysis - By End User
10.2.6 Europe Alpha Thalassemia Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Alpha Thalassemia Market
10.2.6.1.1 Germany Alpha Thalassemia Market by Type
10.2.6.1.2 Germany Alpha Thalassemia Market by Diagnosis
10.2.6.1.3 Germany Alpha Thalassemia Market by End User
10.2.6.2 France Alpha Thalassemia Market
10.2.6.2.1 France Alpha Thalassemia Market by Type
10.2.6.2.2 France Alpha Thalassemia Market by Diagnosis
10.2.6.2.3 France Alpha Thalassemia Market by End User
10.2.6.3 Italy Alpha Thalassemia Market
10.2.6.3.1 Italy Alpha Thalassemia Market by Type
10.2.6.3.2 Italy Alpha Thalassemia Market by Diagnosis
10.2.6.3.3 Italy Alpha Thalassemia Market by End User
10.2.6.4 Spain Alpha Thalassemia Market
10.2.6.4.1 Spain Alpha Thalassemia Market by Type
10.2.6.4.2 Spain Alpha Thalassemia Market by Diagnosis
10.2.6.4.3 Spain Alpha Thalassemia Market by End User
10.2.6.5 United Kingdom Alpha Thalassemia Market
10.2.6.5.1 United Kingdom Alpha Thalassemia Market by Type
10.2.6.5.2 United Kingdom Alpha Thalassemia Market by Diagnosis
10.2.6.5.3 United Kingdom Alpha Thalassemia Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Alpha Thalassemia Market Overview
10.3.2 Asia-Pacific Alpha Thalassemia Market Forecasts and Analysis
10.3.3 Asia-Pacific Alpha Thalassemia Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Alpha Thalassemia Market Forecasts and Analysis - By Diagnosis
10.3.5 Asia-Pacific Alpha Thalassemia Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Alpha Thalassemia Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Alpha Thalassemia Market
10.3.6.1.1 Australia Alpha Thalassemia Market by Type
10.3.6.1.2 Australia Alpha Thalassemia Market by Diagnosis
10.3.6.1.3 Australia Alpha Thalassemia Market by End User
10.3.6.2 China Alpha Thalassemia Market
10.3.6.2.1 China Alpha Thalassemia Market by Type
10.3.6.2.2 China Alpha Thalassemia Market by Diagnosis
10.3.6.2.3 China Alpha Thalassemia Market by End User
10.3.6.3 India Alpha Thalassemia Market
10.3.6.3.1 India Alpha Thalassemia Market by Type
10.3.6.3.2 India Alpha Thalassemia Market by Diagnosis
10.3.6.3.3 India Alpha Thalassemia Market by End User
10.3.6.4 Japan Alpha Thalassemia Market
10.3.6.4.1 Japan Alpha Thalassemia Market by Type
10.3.6.4.2 Japan Alpha Thalassemia Market by Diagnosis
10.3.6.4.3 Japan Alpha Thalassemia Market by End User
10.3.6.5 South Korea Alpha Thalassemia Market
10.3.6.5.1 South Korea Alpha Thalassemia Market by Type
10.3.6.5.2 South Korea Alpha Thalassemia Market by Diagnosis
10.3.6.5.3 South Korea Alpha Thalassemia Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Alpha Thalassemia Market Overview
10.4.2 Middle East and Africa Alpha Thalassemia Market Forecasts and Analysis
10.4.3 Middle East and Africa Alpha Thalassemia Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Alpha Thalassemia Market Forecasts and Analysis - By Diagnosis
10.4.5 Middle East and Africa Alpha Thalassemia Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Alpha Thalassemia Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Alpha Thalassemia Market
10.4.6.1.1 South Africa Alpha Thalassemia Market by Type
10.4.6.1.2 South Africa Alpha Thalassemia Market by Diagnosis
10.4.6.1.3 South Africa Alpha Thalassemia Market by End User
10.4.6.2 Saudi Arabia Alpha Thalassemia Market
10.4.6.2.1 Saudi Arabia Alpha Thalassemia Market by Type
10.4.6.2.2 Saudi Arabia Alpha Thalassemia Market by Diagnosis
10.4.6.2.3 Saudi Arabia Alpha Thalassemia Market by End User
10.4.6.3 U.A.E Alpha Thalassemia Market
10.4.6.3.1 U.A.E Alpha Thalassemia Market by Type
10.4.6.3.2 U.A.E Alpha Thalassemia Market by Diagnosis
10.4.6.3.3 U.A.E Alpha Thalassemia Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Alpha Thalassemia Market Overview
10.5.2 South and Central America Alpha Thalassemia Market Forecasts and Analysis
10.5.3 South and Central America Alpha Thalassemia Market Forecasts and Analysis - By Type
10.5.4 South and Central America Alpha Thalassemia Market Forecasts and Analysis - By Diagnosis
10.5.5 South and Central America Alpha Thalassemia Market Forecasts and Analysis - By End User
10.5.6 South and Central America Alpha Thalassemia Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Alpha Thalassemia Market
10.5.6.1.1 Brazil Alpha Thalassemia Market by Type
10.5.6.1.2 Brazil Alpha Thalassemia Market by Diagnosis
10.5.6.1.3 Brazil Alpha Thalassemia Market by End User
10.5.6.2 Argentina Alpha Thalassemia Market
10.5.6.2.1 Argentina Alpha Thalassemia Market by Type
10.5.6.2.2 Argentina Alpha Thalassemia Market by Diagnosis
10.5.6.2.3 Argentina Alpha Thalassemia Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ALPHA THALASSEMIA MARKET, KEY COMPANY PROFILES
12.1. TRINITY BIOTECH PLC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVUS BIOLOGICALS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. VIENNALAB DIAGNOSTICS GMBH
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIO-RAD LABORATORIES, INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. THERMOFISHER SCIENIFIC CORPORATION INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SEBIA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BLUEBIRD BIO, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NATERA, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EKF DIAGNOSTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SANGAMO THERAPEUTICS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Alpha Thalassemia Market - By Type
1.3.2 Alpha Thalassemia Market - By Diagnosis
1.3.3 Alpha Thalassemia Market - By End User
1.3.4 Alpha Thalassemia Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ALPHA THALASSEMIA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ALPHA THALASSEMIA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ALPHA THALASSEMIA MARKET - GLOBAL MARKET ANALYSIS
6.1. ALPHA THALASSEMIA - GLOBAL MARKET OVERVIEW
6.2. ALPHA THALASSEMIA - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ALPHA THALASSEMIA MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SILENT ALPHA THALASSEMIA CARRIER
7.3.1. Overview
7.3.2. Silent Alpha Thalassemia Carrier Market Forecast and Analysis
7.4. ALPHA THALASSEMIA MINOR
7.4.1. Overview
7.4.2. Alpha Thalassemia Minor Market Forecast and Analysis
7.5. ALPHA THALASSEMIA TRAIT
7.5.1. Overview
7.5.2. Alpha Thalassemia Trait Market Forecast and Analysis
7.6. HEMOGLOBIN H DISEASE
7.6.1. Overview
7.6.2. Hemoglobin H Disease Market Forecast and Analysis
7.7. ALPHA THALASSEMIA MAJOR
7.7.1. Overview
7.7.2. Alpha Thalassemia Major Market Forecast and Analysis
7.8. HYDROPS FETALIS
7.8.1. Overview
7.8.2. Hydrops Fetalis Market Forecast and Analysis
8. ALPHA THALASSEMIA MARKET - REVENUE AND FORECASTS TO 2027 - DIAGNOSIS
8.1. OVERVIEW
8.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
8.3. PRENATAL TESTING
8.3.1. Overview
8.3.2. Prenatal Testing Market Forecast and Analysis
8.4. PERINATAL TESTING
8.4.1. Overview
8.4.2. Perinatal Testing Market Forecast and Analysis
8.5. PRE-IMPLANTATION
8.5.1. Overview
8.5.2. Pre-Implantation Market Forecast and Analysis
9. ALPHA THALASSEMIA MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTIC LABORATORIES
9.4.1. Overview
9.4.2. Diagnostic Laboratories Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. ALPHA THALASSEMIA MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Alpha Thalassemia Market Overview
10.1.2 North America Alpha Thalassemia Market Forecasts and Analysis
10.1.3 North America Alpha Thalassemia Market Forecasts and Analysis - By Type
10.1.4 North America Alpha Thalassemia Market Forecasts and Analysis - By Diagnosis
10.1.5 North America Alpha Thalassemia Market Forecasts and Analysis - By End User
10.1.6 North America Alpha Thalassemia Market Forecasts and Analysis - By Countries
10.1.6.1 United States Alpha Thalassemia Market
10.1.6.1.1 United States Alpha Thalassemia Market by Type
10.1.6.1.2 United States Alpha Thalassemia Market by Diagnosis
10.1.6.1.3 United States Alpha Thalassemia Market by End User
10.1.6.2 Canada Alpha Thalassemia Market
10.1.6.2.1 Canada Alpha Thalassemia Market by Type
10.1.6.2.2 Canada Alpha Thalassemia Market by Diagnosis
10.1.6.2.3 Canada Alpha Thalassemia Market by End User
10.1.6.3 Mexico Alpha Thalassemia Market
10.1.6.3.1 Mexico Alpha Thalassemia Market by Type
10.1.6.3.2 Mexico Alpha Thalassemia Market by Diagnosis
10.1.6.3.3 Mexico Alpha Thalassemia Market by End User
10.2. EUROPE
10.2.1 Europe Alpha Thalassemia Market Overview
10.2.2 Europe Alpha Thalassemia Market Forecasts and Analysis
10.2.3 Europe Alpha Thalassemia Market Forecasts and Analysis - By Type
10.2.4 Europe Alpha Thalassemia Market Forecasts and Analysis - By Diagnosis
10.2.5 Europe Alpha Thalassemia Market Forecasts and Analysis - By End User
10.2.6 Europe Alpha Thalassemia Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Alpha Thalassemia Market
10.2.6.1.1 Germany Alpha Thalassemia Market by Type
10.2.6.1.2 Germany Alpha Thalassemia Market by Diagnosis
10.2.6.1.3 Germany Alpha Thalassemia Market by End User
10.2.6.2 France Alpha Thalassemia Market
10.2.6.2.1 France Alpha Thalassemia Market by Type
10.2.6.2.2 France Alpha Thalassemia Market by Diagnosis
10.2.6.2.3 France Alpha Thalassemia Market by End User
10.2.6.3 Italy Alpha Thalassemia Market
10.2.6.3.1 Italy Alpha Thalassemia Market by Type
10.2.6.3.2 Italy Alpha Thalassemia Market by Diagnosis
10.2.6.3.3 Italy Alpha Thalassemia Market by End User
10.2.6.4 Spain Alpha Thalassemia Market
10.2.6.4.1 Spain Alpha Thalassemia Market by Type
10.2.6.4.2 Spain Alpha Thalassemia Market by Diagnosis
10.2.6.4.3 Spain Alpha Thalassemia Market by End User
10.2.6.5 United Kingdom Alpha Thalassemia Market
10.2.6.5.1 United Kingdom Alpha Thalassemia Market by Type
10.2.6.5.2 United Kingdom Alpha Thalassemia Market by Diagnosis
10.2.6.5.3 United Kingdom Alpha Thalassemia Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Alpha Thalassemia Market Overview
10.3.2 Asia-Pacific Alpha Thalassemia Market Forecasts and Analysis
10.3.3 Asia-Pacific Alpha Thalassemia Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Alpha Thalassemia Market Forecasts and Analysis - By Diagnosis
10.3.5 Asia-Pacific Alpha Thalassemia Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Alpha Thalassemia Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Alpha Thalassemia Market
10.3.6.1.1 Australia Alpha Thalassemia Market by Type
10.3.6.1.2 Australia Alpha Thalassemia Market by Diagnosis
10.3.6.1.3 Australia Alpha Thalassemia Market by End User
10.3.6.2 China Alpha Thalassemia Market
10.3.6.2.1 China Alpha Thalassemia Market by Type
10.3.6.2.2 China Alpha Thalassemia Market by Diagnosis
10.3.6.2.3 China Alpha Thalassemia Market by End User
10.3.6.3 India Alpha Thalassemia Market
10.3.6.3.1 India Alpha Thalassemia Market by Type
10.3.6.3.2 India Alpha Thalassemia Market by Diagnosis
10.3.6.3.3 India Alpha Thalassemia Market by End User
10.3.6.4 Japan Alpha Thalassemia Market
10.3.6.4.1 Japan Alpha Thalassemia Market by Type
10.3.6.4.2 Japan Alpha Thalassemia Market by Diagnosis
10.3.6.4.3 Japan Alpha Thalassemia Market by End User
10.3.6.5 South Korea Alpha Thalassemia Market
10.3.6.5.1 South Korea Alpha Thalassemia Market by Type
10.3.6.5.2 South Korea Alpha Thalassemia Market by Diagnosis
10.3.6.5.3 South Korea Alpha Thalassemia Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Alpha Thalassemia Market Overview
10.4.2 Middle East and Africa Alpha Thalassemia Market Forecasts and Analysis
10.4.3 Middle East and Africa Alpha Thalassemia Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Alpha Thalassemia Market Forecasts and Analysis - By Diagnosis
10.4.5 Middle East and Africa Alpha Thalassemia Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Alpha Thalassemia Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Alpha Thalassemia Market
10.4.6.1.1 South Africa Alpha Thalassemia Market by Type
10.4.6.1.2 South Africa Alpha Thalassemia Market by Diagnosis
10.4.6.1.3 South Africa Alpha Thalassemia Market by End User
10.4.6.2 Saudi Arabia Alpha Thalassemia Market
10.4.6.2.1 Saudi Arabia Alpha Thalassemia Market by Type
10.4.6.2.2 Saudi Arabia Alpha Thalassemia Market by Diagnosis
10.4.6.2.3 Saudi Arabia Alpha Thalassemia Market by End User
10.4.6.3 U.A.E Alpha Thalassemia Market
10.4.6.3.1 U.A.E Alpha Thalassemia Market by Type
10.4.6.3.2 U.A.E Alpha Thalassemia Market by Diagnosis
10.4.6.3.3 U.A.E Alpha Thalassemia Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Alpha Thalassemia Market Overview
10.5.2 South and Central America Alpha Thalassemia Market Forecasts and Analysis
10.5.3 South and Central America Alpha Thalassemia Market Forecasts and Analysis - By Type
10.5.4 South and Central America Alpha Thalassemia Market Forecasts and Analysis - By Diagnosis
10.5.5 South and Central America Alpha Thalassemia Market Forecasts and Analysis - By End User
10.5.6 South and Central America Alpha Thalassemia Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Alpha Thalassemia Market
10.5.6.1.1 Brazil Alpha Thalassemia Market by Type
10.5.6.1.2 Brazil Alpha Thalassemia Market by Diagnosis
10.5.6.1.3 Brazil Alpha Thalassemia Market by End User
10.5.6.2 Argentina Alpha Thalassemia Market
10.5.6.2.1 Argentina Alpha Thalassemia Market by Type
10.5.6.2.2 Argentina Alpha Thalassemia Market by Diagnosis
10.5.6.2.3 Argentina Alpha Thalassemia Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ALPHA THALASSEMIA MARKET, KEY COMPANY PROFILES
12.1. TRINITY BIOTECH PLC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVUS BIOLOGICALS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. VIENNALAB DIAGNOSTICS GMBH
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIO-RAD LABORATORIES, INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. THERMOFISHER SCIENIFIC CORPORATION INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SEBIA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BLUEBIRD BIO, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NATERA, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EKF DIAGNOSTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SANGAMO THERAPEUTICS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Trinity Biotech Plc
2. Novus Biologicals
3. Viennalab Diagnostics Gmbh
4. Bio-Rad Laboratories, Inc
5. Thermofisher Scienific Corporation Inc
6. Sebia
7. Bluebird Bio, Inc.
8. Natera, Inc.
9. EKF Diagnostics
10. Sangamo Therapeutics
1. Trinity Biotech Plc
2. Novus Biologicals
3. Viennalab Diagnostics Gmbh
4. Bio-Rad Laboratories, Inc
5. Thermofisher Scienific Corporation Inc
6. Sebia
7. Bluebird Bio, Inc.
8. Natera, Inc.
9. EKF Diagnostics
10. Sangamo Therapeutics